Abstract
Background
Recent studies have shown that IgG4 is increased in the esophageal tissue of eosinophilic
esophagitis patients, including the presence of IgG4+ plasma cells.
Aims
Our aim was to determine whether IgG4 is elevated in the gastric or duodenal tissue
of pediatric patients with eosinophilic gastritis or duodenitis (EoG or EoD).
Methods
This was a retrospective single center study. Pediatric patients were characterized
as having active EoG, EoD, or as controls based on clinical symptoms and histologic
features. Immunohistochemistry for IgG4 was performed in gastric and duodenal tissue,
and peak IgG4+ cells were compared between groups and after treatment.
Results
The frequency of IgG4+ cells was significantly higher in patients with EoG and EoD
compared to controls in the stomach [EoG 6.5 cells/hpf (3.6-10.9), control 0 cells/hpf
(0-0.7), p<0.0001] and duodenum [EoD 7.5 cells/hpf (2.8-37), control 0.5 cells/hpf
(0.3-1.3), p<0.001)] respectively, and positively correlated with eosinophil counts
(stomach: r 0.74, p<0.0001; duodenum: r 0.57, p<0.0001). The amount of tissue IgG4
was significantly decreased in patients in remission but not in persistently active
disease.
Conclusions
These data suggest local tissue production of IgG4 may be a universal feature of eosinophilic
gastrointestinal disease that tracks with disease activity.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Clinicopathologic Correlations in Eosinophilic Gastrointestinal Disorders.J Allergy Clin Immunol Pract. 2021; 9: 3258-3266
- Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium.Am J Gastroenterol. 2019; 114: 984-994
- Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis.Am J Gastroenterol. 2022; 117: 697-700
- Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database.J Pediatr Gastroenterol Nutr. 2016; 62: 36-42
- High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases.J Pediatr Gastroenterol Nutr. 2020; 71: 524-529
- Natural history of eosinophilic gastroenteritis.Clin Gastroenterol Hepatol. 2011; 9 (e1): 950-956
- Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis.Ann Allergy Asthma Immunol. 2018; 121: 162-167
- Nonesophageal Eosinophilic Gastrointestinal Disorders: Clinical Care and Future Directions.J Pediatr Gastroenterol Nutr. 2018; 67: 318-321
- Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets.Front Physiol. 2021; 12815842
- The Role of the Environment in Eosinophilic Esophagitis.J Allergy Clin Immunol Pract. 2021; 9: 3268-3274
- Eosinophilic esophagitis: from pathophysiology to management.Minerva Gastroenterol. 2022; 68: 40-48
- Efficacy of Dietary Treatment for Inducing Disease Remission in Eosinophilic Gastroenteritis.J Pediatr Gastroenterol Nutr. 2015; 61: 56-64
- Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up.J Pediatr Gastroenterol Nutr. 2006; 42: 516-521
- Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy.Am J Gastroenterol. 2014; 109: 1277-1285
- Eosinophilic Gastritis With Linear Arrays of Pseudopolyps in the Antrum Treated With Exclusive Enteral Nutrition.J Pediatr Gastroenterol Nutr. 2022; 74: e127
- Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.J Allergy Clin Immunol. 2014; 134: 1114-1124
- Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study.J Allergy Clin Immunol. 2020; 145: 255-269
- Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.Gastroenterology. 2014; 147: 602-609
- Specific IgG4 antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitis.J Allergy Clin Immunol. 2018; 142 (e12): 139-148
- Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens.J Allergy Clin Immunol. 2013; 131 (e1–3): 128-134
- Pediatric Eosinophilic Esophagitis Is Associated With Increased Lamina Propria Immunoglobulin G4-Positive Plasma Cells.J Pediatr Gastroenterol Nutr. 2018; 67: 204-209
- Esophageal IgG4: Clinical, Endoscopic, and Histologic Correlations in Eosinophilic Esophagitis.J Pediatr Gastroenterol Nutr. 2019; 68: 689-694
- IgG4 is Elevated in Eosinophilic Esophagitis but Not in Gastroesophageal Reflux Disease Patients.J Clin Gastroenterol. 2020; 54: 43-49
- Oesophageal intrasquamous IgG4 deposits: an adjunctive marker to distinguish eosinophilic oesophagitis from reflux oesophagitis.Histopathology. 2016; 68: 968-976
- Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis.Allergy. 2018; 73: 1892-1901
- Food-specific IgG4 is associated with eosinophilic esophagitis.J Allergy Clin Immunol. 2016; 138 (e3): 1190-1192
- Gastrointestinal IgG4 Deposition Is a New Histopathological Feature of Eosinophilic Gastroenteritis.Dig Dis Sci. 2021; https://doi.org/10.1007/s10620-021-07244-3
- Non-oesophageal eosinophilic gastrointestinal diseases are undersuspected clinically and underdiagnosed pathologically.Aliment Pharmacol Ther. 2022; https://doi.org/10.1111/apt.16971
- NIH Image to ImageJ: 25 years of image analysis.Nature Methods. 2012; 9: 671-675
- Distinguishing gastroesophageal reflux disease and eosinophilic esophagitis in adults: The role of esophageal mucosal immunoglobulin G4.JGH Open. 2020; 4: 851-855
- Presence of intraepithelial food antigen in patients with active eosinophilic oesophagitis.Aliment Pharmacol Ther. 2017; 45: 427-433
- Mucosal penetration and clearance of gluten and milk antigens in eosinophilic oesophagitis.Aliment Pharmacol Ther. 2021; 53: 410-417
- Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study.Lancet. 2001; 357: 752-756
- Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.J Immunol. 1983; 130: 722-726
- Inhibition of complement activation by IgG4 antibodies.Clin Exp Immunol. 1986; 64: 415-422
- Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency.J Immunol. 1986; 137: 3566-3571
- Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange.Science. 2007; 317: 1554-1557
- Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions.J Immunol. 2009; 182: 4275-4281
- Fc-Fc interactions of human IgG4 require dissociation of heavy chains and are formed predominantly by the intra-chain hinge isomer.Mol Immunol. 2013; 53: 35-42
- Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy.Clin Gastroenterol Hepatol. 2021; 19 (e14): 1151-1159
- Food allergy, eosinophilic esophagitis, and the enigma of IgG4.Ann Allergy Asthma Immunol. 2019; 122: 563-564
- Autoimmune pancreatitis and complement activation system.Pancreas. 2006; 32: 16-21
- MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.PLoS One. 2013; 8: e80695
- Serum IgG4 to food proteins, but not to the barrier function proteins desmoglein 1 or 3, are increased in eosinophilic esophagitis.J Allergy Clin Immunol. 2017; 139: AB50
- A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis.Clin Transl Gastroenterol. 2019; 10: e00099
- Food-specific antibodies in oesophageal secretions: association with trigger foods in eosinophilic oesophagitis.Aliment Pharmacol Ther. 2020; 52: 997-1007
- Peripheral markers of allergen-specific immune activation predict clinical allergy in eosinophilic esophagitis.Allergy. 2021; 76: 3470-3478
- Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort.Am J Gastroenterol. 2022; 117: 413-423
Article info
Publication history
Published online: September 02, 2022
Accepted:
August 14,
2022
Received:
June 24,
2022
Footnotes
University of Colorado School of Medicine, 13001 E 17th Pl, Aurora, CO 80045
Sources of Support: T32DK067009 - LAQ, K23DK109263-05 - CMK, R01AI121186 - LAS
Identification
Copyright
© 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.